AC Immune’s Mixed Phase II Results Buoy Alzheimer’s Research
An Alzheimer’s disease drug developed by AC Immune and Genentech has drawn conflicting phase II…
02/09/2021 - 5 minutes
TauRX
Scotland’s Top 10 Biotech Companies to Watch Out For
Scotland has a thriving life sciences ecosystem with strengths in oncology, genetic engineering, and industrial…
30/06/2021 - 11 minutes
Money, Money, Money! Europe’s Best-Funded Biotechs in 2018
Besides struggling with ambitious New Year’s resolutions and post-holiday diets, January is a time where…
20/02/2018 - 11 minutes
Interviews, Reviews and Tops: Our Best Biotech Articles from 2017
We love hearing from our readers, and we listen to what they like! Here are…
26/12/2017 - 6 minutes
“Alzheimer’s is the Last Unclaimed Therapeutic Space,” says TauRx exec
The Alzheimer’s field has been hit with a number of failures. I spoke to the…
10/04/2017 - 7 minutes
What are the Best Countries to Recruit Biotech Talents in 2017?
Before the “who to recruit” phase, an important question is “where?” We ran through the…
15/03/2017 - 10 minutes
World Mental Health Day: How is Biotech Helping the Cause?
Biotech is one of the main forces driving the development of effective therapies to treat neurological and…
11/10/2016 - 4 minutes
World first Drug to ‘dissolve’ Tau-tangles in Alzheimer’s has Phase III Results
The much-anticipated results of TauRx's Phase III trial for Alzheimer's disease have finally been disclosed. Despite…
28/07/2016 - 3 minutes
Also Using PD-L1 Cancer Treatments to Attack Alzheimer’s Disease
What updates have occurred in the Neurodegenerative disease field as of late? New appointments by…
25/01/2016 - 3 minutes
10 Hot European Biotechs to watch in 2016
Looking forward to 2016, I wondered which Biotechs I would watch closely. Here's my list…
12/01/2016 - 6 minutes
Neurodegenerative Disease in the UK: Takeda, NIHR & UCL Research Collaboration
Takeda Cambridge (the UK subsidiary of global biotech Takeda Pharmaceuticals) will now collaborate with University…
15/10/2015 - 2 minutes
What Happened this Week? Nobel prize slips through CRISPR’s fingers, inside iGEM’s Jamboree and €120M boost for Alzheimer’s research
Monday: Manfred Horst on MSD, Biosimilars, KEYTRUDA and Merck & Co.’s rich history Tuesday: An Insider’s experience…
10/10/2015 - 1 minute
